Repository logo

Statistics for Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)

Total visits

views
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1) 23

Total visits per month

views
June 2025 0
July 2025 0
August 2025 0
September 2025 0
October 2025 0
November 2025 0
December 2025 1

File Visits

views
jco.21.00086.pdf 90

Top country views

views
United States 13
Portugal 4
Singapore 3
Angola 1
Canada 1
China 1